Evolus Q2 2024 Adj. EPS $(0.04) Beats $(0.05) Estimate, Sales $66.909M Beat $65.784M Estimate
Portfolio Pulse from Benzinga Newsdesk
Evolus (NASDAQ:EOLS) reported Q2 2024 adjusted EPS of $(0.04), beating the estimate of $(0.05). Sales were $66.909M, surpassing the $65.784M estimate and marking a 35.59% increase from the same period last year.
July 31, 2024 | 9:53 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evolus reported better-than-expected Q2 2024 results with an adjusted EPS of $(0.04) beating the $(0.05) estimate and sales of $66.909M surpassing the $65.784M estimate. Sales increased by 35.59% YoY.
Evolus' better-than-expected earnings and revenue growth indicate strong performance, likely leading to positive short-term stock price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100